🇺🇸 RCUS — Arcus Biosciences, Inc.
Salud Compra fuertePrecio actual
19,31 USD
Máx. histórico
48,47
1807 días
Caída desde máximo
-60,16%
Rango 52 semanas
17,43 – 31,74
Variación hoy
+2,12%
Cierre anterior
18,91
Rango de hoy
18,60 – 19,61
Volumen hoy
2.076.185
Peor caída histórica
-85,83%
23/11/2021 → 04/04/2025
Aún sin recuperar
Volatilidad anualizada ⓘ
75,61%
- Nombre completo
- Arcus Biosciences, Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 601
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 41,00 USD (puede no estar actualizado)
- Primera cotización
- 15/03/2018
- Precio actualizado
- hace 1 hora
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company's development product portfolio includes Casdatifan, a HIF-2a inhibitor for the treatment of kidney cancer; Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial for lung and gastrointestinal cancers; and Zimberelimab, an anti-PD-1 antibody. It also develops Quemliclustat, a small molecule inhibitor that targets the CD73 enzyme in the ATP-adenosine pathway, which is in phase 3 and phase 1/1b clinical trial for lung and pancreatic cancer. In addition, the company develops AB598, a CD39 antibody, which is in phase 1/1b clinical study for gastrointestinal cancer and AB801, an AXL inhibitor, which is in Phase 1b clinical trial for lung cancer. It has clinical collaboration with AstraZeneca for the Phase 3 PACIFIC-8 trial evaluating domvanalimab and durvalumab in Stage 3 NSCLC and for a Phase 1/1b study evaluating casdatifan and volrustomig in IO-naive patients with ccRCC; BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases; and Bristol-Myers Squibb Company to develop a novel treatment regimen that delivers tumor control in kidney cancer. Arcus Biosciences, Inc. was incorporated in 2015 and is based in Hayward, California.
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/05/2025 | 9,38 | 9,38 | 8,55 | 8,93 | -6,10% | 8,85% | 1.379.600 |
| 29/05/2025 | 9,25 | 9,61 | 9,01 | 9,51 | +4,16% | 6,49% | 1.495.100 |
| 28/05/2025 | 9,04 | 9,31 | 8,93 | 9,13 | +1,11% | 4,20% | 746.900 |
| 27/05/2025 | 9,15 | 9,27 | 8,82 | 9,03 | +0,11% | 4,97% | 1.597.500 |
| 23/05/2025 | 8,62 | 9,12 | 8,50 | 9,02 | +2,73% | 7,19% | 901.300 |
| 22/05/2025 | 8,50 | 8,84 | 8,42 | 8,78 | +1,97% | 4,88% | 960.500 |
| 21/05/2025 | 8,69 | 8,87 | 8,58 | 8,61 | -2,93% | 3,34% | 1.160.700 |
| 20/05/2025 | 8,73 | 9,09 | 8,54 | 8,87 | +1,84% | 6,30% | 910.300 |
| 19/05/2025 | 8,43 | 8,91 | 8,38 | 8,71 | +1,75% | 6,23% | 1.228.900 |
| 16/05/2025 | 8,63 | 8,87 | 8,53 | 8,56 | -0,12% | 3,94% | 920.700 |
| 15/05/2025 | 8,47 | 8,74 | 8,26 | 8,57 | +0,35% | 5,61% | 789.800 |
| 14/05/2025 | 8,61 | 8,84 | 8,38 | 8,54 | -1,50% | 5,40% | 849.100 |
| 13/05/2025 | 8,77 | 8,82 | 8,34 | 8,67 | -1,48% | 5,42% | 1.055.100 |
| 12/05/2025 | 8,60 | 9,00 | 8,51 | 8,80 | +6,28% | 5,70% | 2.674.600 |
| 09/05/2025 | 8,46 | 8,88 | 8,26 | 8,28 | -2,93% | 7,27% | 1.185.700 |
| 08/05/2025 | 7,96 | 8,58 | 7,72 | 8,53 | +6,49% | 10,87% | 1.349.900 |
| 07/05/2025 | 7,44 | 8,01 | 7,06 | 8,01 | -1,35% | 12,77% | 2.211.100 |
| 06/05/2025 | 8,85 | 8,89 | 8,09 | 8,12 | -9,17% | 9,10% | 919.500 |
| 05/05/2025 | 9,04 | 9,10 | 8,78 | 8,94 | -1,97% | 3,60% | 818.600 |
| 02/05/2025 | 8,71 | 9,35 | 8,65 | 9,12 | +5,80% | 8,04% | 1.304.600 |
| 01/05/2025 | 8,72 | 8,76 | 8,45 | 8,62 | -1,49% | 3,56% | 848.100 |
| 30/04/2025 | 8,03 | 8,76 | 7,85 | 8,75 | +7,63% | 11,33% | 1.513.500 |
| 29/04/2025 | 8,26 | 8,27 | 8,01 | 8,13 | -1,45% | 3,17% | 1.091.300 |
| 28/04/2025 | 8,29 | 8,46 | 8,12 | 8,25 | -0,60% | 4,10% | 1.348.100 |
| 25/04/2025 | 8,16 | 8,34 | 8,07 | 8,30 | -1,31% | 3,25% | 503.700 |
| 24/04/2025 | 8,22 | 8,48 | 8,07 | 8,41 | +3,70% | 4,99% | 859.400 |
| 23/04/2025 | 8,21 | 8,51 | 8,00 | 8,11 | +0,25% | 6,21% | 3.184.500 |
| 22/04/2025 | 7,80 | 8,14 | 7,76 | 8,09 | +4,93% | 4,94% | 1.059.600 |
| 21/04/2025 | 7,71 | 8,00 | 7,65 | 7,71 | -2,16% | 4,54% | 1.163.400 |
| 17/04/2025 | 7,88 | 7,97 | 7,73 | 7,88 | +0,38% | 3,05% | 812.300 |